Nck adaptor proteins modulate differentiation and effector function of T cells.

Saved in:
Bibliographic Details
Title: Nck adaptor proteins modulate differentiation and effector function of T cells.
Authors: Lu KH; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Keppler S; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Leithäuser F; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Mattfeldt T; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Castello A; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Kostezka U; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Küblbeck G; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Schmitt S; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Klevenz A; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Prokosch S; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Pougialis G; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Pawson T; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Batista F; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Tafuri A; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Arnold B; Molecular Immunology, German Cancer Research Center, Heidelberg, Germany; Lymphocyte Interaction Laboratory, London Research Institute-Cancer Research UK, London, United Kingdom; Department of Pathology, Universitätsklinikum, Ulm, Germany; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada b.arnold@dkfz.de.
Source: Journal of leukocyte biology [J Leukoc Biol] 2015 Sep; Vol. 98 (3), pp. 301-11. Date of Electronic Publication: 2015 May 20.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 8405628 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-3673 (Electronic) Linking ISSN: 07415400 NLM ISO Abbreviation: J Leukoc Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1938-3673
DOI:10.1189/jlb.1HI1114-565R